Besides, we also analyzed the proportion of CD3+CD4+T cells in tumors and found that the tumor bearing mice treated with glycosylated-PEG-oHSV contained a relatively higher percentage of CD3+CD4+T cells compared to tumors treated with PBS or oHSV alone (Figure S11). The gene discussed is CD4; the disease is neoplasm.